+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Consumer Genomics Market Size, Share & Trends Analysis Report by Application (Genetic Relatedness, Ancestry, Diagnostics, Sports Nutrition & Health), Region (North America, Europe), and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 110 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 4827932
Description Jump to:
The global consumer genomics market size is expected to reach USD 7.20 billion by 2030, registering a CAGR of 24.8% from 2023 to 2030, according to the report. The rise in consumer and physician interest in direct-to-consumer (DTC) kits, coupled with a subsequent increase in the sales of DNA test kits, and the growing trend of personalized genomics, are expected to drive market expansion over the forecast period. The most common tests utilize a small number of genetic changes to predict certain health characteristics, reveal common traits, and provide ancestry hints. With the expansion of the variety of health information these tests can uncover, an increasing number of companies are offering genetic testing directly to consumers.

The surge in consumer and physician interest in DTC kits, technological improvements, an increase in consumer genomics applications, supportive governmental policies, and the growing trend of personalized genomics are the primary drivers of market expansion. For instance, according to a ScienceDirect article, direct-to-consumer (DTC) tests became more prevalent in 2022 as they could be purchased without a doctor's prescription.

The COVID-19 pandemichas heightened people's concerns about their health, potentially encouraging them to explore novel and cutting-edge methods like consumer genomics. Therefore, the market is expected to maintain its considerable growth rate over the forecast period due to the increasing efforts in DNA-based research and development, as well as bioinformatics, aimed at creating diagnostic tools and efficient therapies for COVID-19.

Consumer Genomics Market Report Highlights

  • The genetic relatedness segment accounted for the largest revenue share in 2022 due to its involvement in the most common type of paternal testing
  • The dissolving microneedle segment is expected to grow at the fastest rate during the forecast period since it requires only one step, and the microneedle does not need to be removed after insertion
  • Companies such as FamilyTree DNA; AncestryDNA; 23andMe, Inc.; MyHeritage, and others offer several paternal and maternal tests. These tests provide information about genetic relations and ancestry at an affordable cost
  • Asia Pacific is anticipated to experience the fastest CAGR over the forecast period due to the increasing awareness related to DTC genetics and the availability of funding for long-term research initiatives


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segment & Scope
1.1.1. Application
1.1.2. Regional Scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information Or Data Analysis
1.4.1. Data Analysis Model
1.5. Market Scope & Segment Definition
1.6. Market Model
1.6.1. Market Study, By Company Market Share
1.6.2. Regional Analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
3.2.1.2. Increase in access to DTC services due to reducing cost of genotyping
3.2.1.3. Expansion in applications of DTC genetics
3.2.1.3.1. Health testing
3.2.1.3.2. Ancestry
3.2.1.3.3. Genetic relatedness
3.2.1.4. Significant investments & initiatives by companies to maintain their competitive edge in the market
3.2.1.5. Growing trend of personalized genomics
3.2.2. Market Restraint Analysis
3.2.2.1. Ethical and clinical issues pertaining to the use of DTC products & personalized treatment
3.2.2.2. Misleading results create challenges in adoption of home-based genetic tests
3.2.2.3. Regulatory challenges pertaining to the use of DTC genetic tests
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Consumer Genomics Application Business Analysis
4.1. Consumer Genomics Market: Application Movement Analysis
4.2. Genetic Relatedness
4.2.1. Genetic Relatedness Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3. Ancestry
4.3.1. Ancestry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Lifestyle, Wellness, & Nutrition
4.4.1. Lifestyle, Wellness, & Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Diagnostics
4.5.1. Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Sports Nutrition & Health
4.6.1. Sports Nutrition & Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Reproductive Health
4.7.1. Reproductive Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Personalized medicine & Pharmacogenetic testing
4.8.1. Personalized medicine & Pharmacogenetic testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Other Application Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Regional Business Analysis
5.1. Consumer Genomics Market: Regional Market Snapshot
5.2. North America
5.2.1. North America Consumer Genomics Market, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. Key Country Dynamics
5.2.2.2. Target Disease Prevalence
5.2.2.3. Competitive Scenario
5.2.2.4. Regulatory Framework
5.2.2.5. U.S. Consumer Genomics Market, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Key Country Dynamics
5.2.3.2. Target Disease Prevalence
5.2.3.3. Competitive Scenario
5.2.3.4. Regulatory Framework
5.2.3.5. Canada Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. Key Country Dynamics
5.3.2.2. Target Disease Prevalence
5.3.2.3. Competitive Scenario
5.3.2.4. Regulatory Framework
5.3.2.5. UK Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Key Country Dynamics
5.3.3.2. Target Disease Prevalence
5.3.3.3. Competitive Scenario
5.3.3.4. Regulatory Framework
5.3.3.5. Germany Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. Key Country Dynamics
5.3.4.2. Target Disease Prevalence
5.3.4.3. Competitive Scenario
5.3.4.4. Regulatory Framework
5.3.4.5. France Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Key Country Dynamics
5.3.5.2. Target Disease Prevalence
5.3.5.3. Competitive Scenario
5.3.5.4. Regulatory Framework
5.3.5.5. Italy Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Key Country Dynamics
5.3.6.2. Target Disease Prevalence
5.3.6.3. Competitive Scenario
5.3.6.4. Regulatory Framework
5.3.6.5. Spain Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Key Country Dynamics
5.3.7.2. Target Disease Prevalence
5.3.7.3. Competitive Scenario
5.3.7.4. Regulatory Framework
5.3.7.5. Denmark Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Key Country Dynamics
5.3.8.2. Target Disease Prevalence
5.3.8.3. Competitive Scenario
5.3.8.4. Regulatory Framework
5.3.8.5. Sweden Consumer Genomics Market, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Key Country Dynamics
5.3.9.2. Target Disease Prevalence
5.3.9.3. Competitive Scenario
5.3.9.4. Regulatory Framework
5.3.9.5. Norway Consumer Genomics Market, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Consumer Genomics Market, 2018 - 2030 (USD Million)
5.4.2. Japan
5.4.2.1. Key Country Dynamics
5.4.2.2. Target Disease Prevalence
5.4.2.3. Competitive Scenario
5.4.2.4. Regulatory Framework
5.4.2.5. Japan Consumer Genomics Market, 2018 - 2030 (USD Million)
5.4.3. China
5.4.3.1. Key Country Dynamics
5.4.3.2. Target Disease Prevalence
5.4.3.3. Competitive Scenario
5.4.3.4. Regulatory Framework
5.4.3.5. China Consumer Genomics Market, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. Key Country Dynamics
5.4.4.2. Target Disease Prevalence
5.4.4.3. Competitive Scenario
5.4.4.4. Regulatory Framework
5.4.4.5. India Consumer Genomics Market, 2018 - 2030 (USD Million)
5.4.5. Australia
5.4.5.1. Key Country Dynamics
5.4.5.2. Target Disease Prevalence
5.4.5.3. Competitive Scenario
5.4.5.4. Regulatory Framework
5.4.5.5. Australia Consumer Genomics Market, 2018 - 2030 (USD Million)
5.4.6. Switzerland
5.4.6.1. Key Country Dynamics
5.4.6.2. Target Disease Prevalence
5.4.6.3. Competitive Scenario
5.4.6.4. Regulatory Framework
5.4.6.5. Switzerland Consumer Genomics Market, 2018 - 2030 (USD Million)
5.4.7. Thailand
5.4.7.1. Key Country Dynamics
5.4.7.2. Target Disease Prevalence
5.4.7.3. Competitive Scenario
5.4.7.4. Regulatory Framework
5.4.7.5. Thailand Consumer Genomics Market, 2018 - 2030 (USD Million)
5.4.8. South Korea
5.4.8.1. Key Country Dynamics
5.4.8.2. Target Disease Prevalence
5.4.8.3. Competitive Scenario
5.4.8.4. Regulatory Framework
5.4.8.5. South Korea Consumer Genomics Market, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Consumer Genomics Market, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Key Country Dynamics
5.5.2.2. Target Disease Prevalence
5.5.2.3. Competitive Scenario
5.5.2.4. Regulatory Framework
5.5.2.5. Brazil Consumer Genomics Market, 2018 - 2030 (USD Million)
5.5.3. Mexico
5.5.3.1. Key Country Dynamics
5.5.3.2. Target Disease Prevalence
5.5.3.3. Competitive Scenario
5.5.3.4. Regulatory Framework
5.5.3.5. Mexico Consumer Genomics Market, 2018 - 2030 (USD Million)
5.5.4. Argentina
5.5.4.1. Key Country Dynamics
5.5.4.2. Target Disease Prevalence
5.5.4.3. Competitive Scenario
5.5.4.4. Regulatory Framework
5.5.4.5. Argentina Consumer Genomics Market, 2018 - 2030 (USD Million)
5.6. MEA
5.6.1. MEA Consumer Genomics Market, 2018 - 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. Key Country Dynamics
5.6.2.2. Target Disease Prevalence
5.6.2.3. Competitive Scenario
5.6.2.4. Regulatory Framework
5.6.2.5. South Africa Consumer Genomics Market, 2018 - 2030 (USD Million)
5.6.3. Saudi Arabia
5.6.3.1. Key Country Dynamics
5.6.3.2. Target Disease Prevalence
5.6.3.3. Competitive Scenario
5.6.3.4. Regulatory Framework
5.6.3.5. Saudi Arabia Consumer Genomics Market, 2018 - 2030 (USD Million)
5.6.4. UAE
5.6.4.1. Key Country Dynamics
5.6.4.2. Target Disease Prevalence
5.6.4.3. Competitive Scenario
5.6.4.4. Regulatory Framework
5.6.4.5. UAE Consumer Genomics Market, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Key Country Dynamics
5.6.5.2. Target Disease Prevalence
5.6.5.3. Competitive Scenario
5.6.5.4. Regulatory Framework
5.6.5.5. Kuwait Consumer Genomics Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Market Share Analysis, 2022
6.4. Company Profiles/Listing
6.4.1. Ancestry
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. 23andMe, Inc.
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Gene by Gene, Ltd.
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. Mapmygenome
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. Color Health, Inc.
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Positive Biosciences, Ltd.
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Futura Genetics
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Helix OpCo LLC
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. MyHeritage Ltd.
6.4.9.1. Overview
6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Pathway Genomics
6.4.10.1. Overview
6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
6.4.11. Veritas
6.4.11.1. Overview
6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic Initiatives
6.4.12. Myriad Genetics, Inc.
6.4.12.1. Overview
6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic Initiatives
6.4.13. Illumina, Inc.
6.4.13.1. Overview
6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic Initiatives
6.4.14. Amgen, Inc.
6.4.14.1. Overview
6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic Initiatives
6.4.15. Xcode Life
6.4.15.1. Overview
6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.15.3. Product Benchmarking
6.4.15.4. Strategic Initiatives
6.4.16. Diagnomics, Inc.
6.4.16.1. Overview
6.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.16.3. Product Benchmarking
6.4.16.4. Strategic Initiatives
6.4.17. Toolbox Genomics
6.4.17.1. Overview
6.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.17.3. Product Benchmarking
6.4.17.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 List of abbreviation
Table 3 Global consumer genomics market, by region, 2018 - 2030 (USD Million)
Table 4 North America consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 5 North America consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 7 Canada consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 8 Europe consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 9 Europe consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 10 UK consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 11 Germany consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 12 France consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 13 Italy consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 14 Spain consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 15 Denmark consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 16 Sweden consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 17 Norway consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 18 Asia Pacific consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 19 Asia Pacific consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 20 Japan consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 21 China consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 22 India consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 23 Australia consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 24 Switzerland consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 25 Thailand consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 26 South Korea consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 27 Latin America consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 28 Latin America consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 29 Brazil consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 30 Mexico consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 31 Argentina consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 32 Middle East & Africa consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 33 Middle East & Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 34 South Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 35 Saudi Arabia consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 36 UAE consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 37 Kuwait consumer genomics market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Consumer Genomics market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global Consumer Genomics market: Application movement analysis
Fig. 15 Global Consumer Genomics market, for genetic relatedness, 2018 - 2030 (USD Million)
Fig. 16 Global Consumer Genomics market, for ancestry, 2018 - 2030 (USD Million)
Fig. 17 Global Consumer Genomics market, for lifestyle, wellness, & nutrition, 2018 - 2030 (USD Million)
Fig. 18 Global Consumer Genomics market, for diagnostics, 2018 - 2030 (USD Million)
Fig. 19 Global Consumer Genomics market, for sports nutrition & health, 2018 - 2030 (USD Million)
Fig. 20 Global Consumer Genomics market, for reproductive health, 2018 - 2030 (USD Million)
Fig. 21 Global Consumer Genomics market, for personalized medicine & pharmacogenetic testing, 2018 - 2030 (USD Million)
Fig. 22 Global Consumer Genomics market, for other applications, 2018 - 2030 (USD Million)
Fig. 23 Regional marketplace: Key takeaways
Fig. 24 Regional outlook, 2022 & 2030
Fig. 25 Global Consumer Genomics market: Region movement analysis
Fig. 26 North America Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 27 U.S. Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 28 Canada Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 29 Europe Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 30 Germany Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 31 UK Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 32 France Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 33 Italy Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 34 Spain Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 35 Denmark Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 36 Sweden Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 37 Norway Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 39 Japan Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 40 China Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 41 India Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 42 Australia Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 43 Switzerland Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 44 South Korea Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 45 Thailand Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 46 Latin America Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 47 Brazil Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 48 Mexico Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 49 Argentina Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 50 Middle East and Africa Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 51 South Africa Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 52 Saudi Arabia Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 53 UAE Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 54 Kuwait Consumer Genomics market, 2018 - 2030 (USD Million)

Companies Profiled

  • Ancestry
  • 23andMe, Inc.
  • Gene by Gene, Ltd.
  • Mapmygenome
  • Color Health, Inc.
  • Positive Biosciences, Ltd.
  • Futura Genetics
  • Helix OpCo LLC
  • MyHeritage Ltd.
  • Pathway Genomics
  • Veritas
  • Myriad Genetics, Inc.
  • Illumina, Inc.
  • Amgen, Inc.
  • Xcode Life
  • Diagnomics, Inc.
  • Toolbox Genomics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 1.23 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.2 Billion
Compound Annual Growth Rate24.8%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Consumer Genomics Global Market Report 2024 - Product Image

Consumer Genomics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Consumer Genomics Market Report and Forecast 2024-2032 - Product Image

Global Consumer Genomics Market Report and Forecast 2024-2032

  • Report
  • 210 Pages
  • Global
From
Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report - Product Image

Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From

About the Market

Consumer Genomics is a subset of the larger Genomics market, which focuses on the use of genetic information to inform decisions about health and lifestyle. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Consumer Genomics companies offer a range of services, from direct-to-consumer genetic testing to personalized health and wellness programs. These services are designed to provide individuals with insights into their genetic makeup and to help them make informed decisions about their health and lifestyle. Consumer Genomics companies include 23andMe, AncestryDNA, Helix, Color Genomics, and MyHeritage. These companies offer a variety of services, from genetic testing to health and wellness programs. They also provide access to genetic counselors and other healthcare professionals to help individuals understand their results and make informed decisions about their health. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.